Ketamine: Neuroprotective or Neurotoxic?
Ketamine: Neuroprotective or Neurotoxic?
复制标题
DOI:
10.3389/fnins.2021.672526
复制
发表时间:
2021
影响因子:
4.3
通讯作者:
Krishnan V
中科院分区:
文献类型:
--
作者:
Choudhury D;Autry AE;Tolias KF;Krishnan V
Ketamine, a non-competitive N-methyl-D-aspartate receptor (NMDAR) antagonist, has been employed clinically as an intravenous anesthetic since the 1970s. More recently, ketamine has received attention for its rapid antidepressant effects and is actively being explored as a treatment for a wide range of neuropsychiatric syndromes. In model systems, ketamine appears to display a combination of neurotoxic and neuroprotective properties that are context dependent. At anesthetic doses applied during neurodevelopmental windows, ketamine contributes to inflammation, autophagy, apoptosis, and enhances levels of reactive oxygen species. At the same time, subanesthetic dose ketamine is a powerful activator of multiple parallel neurotrophic signaling cascades with neuroprotective actions that are not always NMDAR-dependent. Here, we summarize results from an array of preclinical studies that highlight a complex landscape of intracellular signaling pathways modulated by ketamine and juxtapose the somewhat contrasting neuroprotective and neurotoxic features of this drug.
登录
查看更多内容
影响因子:
13.5
作者:
Abdallah CG;Sanacora G;Duman RS;Krystal JH
通讯作者:
Krystal JH
影响因子:
64.8
作者:
Autry, Anita E.;Adachi, Megunai;Nosyreva, Elena;Na, Elisa S.;Los, Maarten F.;Cheng, Peng-fei;Kavalali, Ege T.;Monteggia, Lisa M.
通讯作者:
Monteggia, Lisa M.
影响因子:
4.8
作者:
Grunebaum, Michael F.;Galfalvy, Hanga C.;Mann, J. John
通讯作者:
Mann, J. John
影响因子:
10.6
作者:
Berman, RM;Cappiello, A;Krystal, JH
通讯作者:
Krystal, JH
影响因子:
5.7
作者:
Bai X;Yan Y;Canfield S;Muravyeva MY;Kikuchi C;Zaja I;Corbett JA;Bosnjak ZJ
通讯作者:
Bosnjak ZJ